United States · Series A startup

Who invested in Arda Therapeutics

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$43Mraised across 1 round since 2024, from 1 source

Latest round
Series A, $43MOct 2024
Investors
4
See who backed them

The rounds

  1. Oct 2024
    Series A$43M

    Source recordedSEC filing: $43M sold, first sale Sept 2024

Everyone who backed them

Andreessen HorowitzVC firm1round
Alumni VenturesVC firm1round
GaingelsPrivate equity1round
Two Sigma VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Arda Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Olima VenturesVC firmPer its own site

Quick answers about Arda Therapeutics

Who invested in Arda Therapeutics?

Arda Therapeutics's investors include Andreessen Horowitz, Alumni Ventures, Gaingels and Two Sigma Ventures.

How much has Arda Therapeutics raised?

Arda Therapeutics has raised $43M across 1 round since 2024.

When did Arda Therapeutics last raise?

Arda Therapeutics's most recent round was a Series A of $43M in Oct 2024.

What was Arda Therapeutics's biggest round?

Its most recent round, $43M in Oct 2024, is also its largest on record.

Who backed Arda Therapeutics first?

Arda Therapeutics's first round on record, in Oct 2024, was backed by Andreessen Horowitz, Alumni Ventures and Gaingels and 1 others.

What stage is Arda Therapeutics at?

Arda Therapeutics's latest named round is a Series A, in Oct 2024.

Where is Arda Therapeutics based?

Arda Therapeutics is based in the United States.

Companies like Arda Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.